Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other financing activities (2016)

Historic Other financing activities for Wave Life Sciences (WVE) over the last 2 years, with Q4 2017 value amounting to $22.2 million.

  • Wave Life Sciences' Other financing activities rose 902427.98% to $22.2 million in Q4 2017 from the same period last year, while for Dec 2017 it was $22.2 million, marking a year-over-year change of. This contributed to the annual value of $22.2 million for FY2017, which is 12107.89% up from last year.
  • As of Q4 2017, Wave Life Sciences' Other financing activities stood at $22.2 million, which was up 902427.98% from $243000.0 recorded in Q4 2016.
  • Wave Life Sciences' 5-year Other financing activities high stood at $22.2 million for Q4 2017, and its period low was $243000.0 during Q4 2016.